제이엘케이

322510KOSDAQ소프트웨어 개발 및 공급업

53.3 / 100

Reference Date: 2026-07-24

Financial Score7.0 / 40

News Sentiment21.3 / 25

Momentum15.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Surged 16.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

JLK is a medical AI solution provider specializing in AI-based analysis of medical imaging, with a focus on stroke diagnosis and prognosis prediction. The company holds 78 global certifications and offers products such as MEDIHUB STROKE and cancer analysis solutions, driving growth in both domestic and international markets.

Number of Employees

87people

Average Salary

88.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 12.284.0Point

PBR

3.37Industry Average 0.890.0Point

3.8x industry avg (risky)

ROE

-30.01Industry Average 1.100.0Point

Well below industry avg

Debt Ratio

21.64Industry Average 7.930.0Point

2.7x industry avg (risky)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲45.6% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼40.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -41.9% (improving, 3yr)

Detailed News Sentiment

7 totalPositive 7Neutral 0Negative 0Average Sentiment Score 85

Positive
제이엘케이, 의료 AI 성능 저하 문제 극복 특허 확보
제이엘케이가 의료 AI 성능 저하 문제 해결을 위한 특허를 확보하여 기술적 우위를 강화했다.
Positive
제이엘케이, 자체 의료 LLM 플랫폼 구동 안정성 입증
제이엘케이의 의료 LLM 플랫폼 'JOOMED'가 안정성을 입증하며 기술적 성과를 보여주어 긍정적인 시장 반응을 기대할 수 있다.
Positive
제이엘케이, 인텔 GPU 검증...LLM 경쟁력 입증
제이엘케이는 인텔과의 협력으로 저비용 LLM 플랫폼을 확보하여 경쟁력을 강화했다.

Detailed Momentum

52-week position3.0Point

52w lower range (29%)

Current 5,420Won52-week high 9,00052-week low 3,940

1-month return6.0Point

1m +16.81% (strong rise)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral주주명부폐쇄기간또는기준일설정2026-07-09
Neutral주주총회소집결의 (임시주주총회)2026-07-09